Logo image of IVP

INSPIRE VETERINARY PARTNE-A (IVP) Stock Fundamental Analysis

NASDAQ:IVP - Nasdaq - US45784E2054 - Common Stock

0.1477  0 (-2.83%)

Fundamental Rating

1

Overall IVP gets a fundamental rating of 1 out of 10. We evaluated IVP against 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of IVP have multiple concerns. IVP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IVP had negative earnings in the past year.
In the past year IVP has reported a negative cash flow from operations.
IVP Yearly Net Income VS EBIT VS OCF VS FCFIVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

The Return On Assets of IVP (-66.07%) is worse than 88.78% of its industry peers.
IVP has a worse Return On Equity (-488.38%) than 86.92% of its industry peers.
Industry RankSector Rank
ROA -66.07%
ROE -488.38%
ROIC N/A
ROA(3y)-38.16%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVP Yearly ROA, ROE, ROICIVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 17.00%, IVP is doing worse than 67.29% of the companies in the same industry.
IVP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVP Yearly Profit, Operating, Gross MarginsIVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

IVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
IVP has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, IVP has an improved debt to assets ratio.
IVP Yearly Shares OutstandingIVP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M 4M
IVP Yearly Total Debt VS Total AssetsIVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -2.50, we must say that IVP is in the distress zone and has some risk of bankruptcy.
IVP has a worse Altman-Z score (-2.50) than 85.98% of its industry peers.
IVP has a Debt/Equity ratio of 4.34. This is a high value indicating a heavy dependency on external financing.
IVP's Debt to Equity ratio of 4.34 is on the low side compared to the rest of the industry. IVP is outperformed by 81.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.34
Debt/FCF N/A
Altman-Z -2.5
ROIC/WACCN/A
WACC7.44%
IVP Yearly LT Debt VS Equity VS FCFIVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

IVP has a Current Ratio of 0.63. This is a bad value and indicates that IVP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.63, IVP is doing worse than 87.85% of the companies in the same industry.
A Quick Ratio of 0.55 indicates that IVP may have some problems paying its short term obligations.
IVP's Quick ratio of 0.55 is on the low side compared to the rest of the industry. IVP is outperformed by 85.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.55
IVP Yearly Current Assets VS Current LiabilitesIVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M

More info and screens

1

3. Growth

3.1 Past

IVP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.70%, which is quite impressive.
Looking at the last year, IVP shows a small growth in Revenue. The Revenue has grown by 6.12% in the last year.
EPS 1Y (TTM)93.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.69%
Revenue 1Y (TTM)6.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVP Yearly Revenue VS EstimatesIVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 5M 10M 15M
IVP Yearly EPS VS EstimatesIVP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IVP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVP Price Earnings VS Forward Price EarningsIVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVP Per share dataIVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IVP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIRE VETERINARY PARTNE-A

NASDAQ:IVP (1/22/2025, 12:52:52 PM)

0.1477

0 (-2.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.33%
Inst Owner Change-0.73%
Ins Owners2.8%
Ins Owner Change0%
Market Cap4.79M
AnalystsN/A
Price TargetN/A
Short Float %0.41%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 1.58
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.5
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.53
BVpS0.09
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -66.07%
ROE -488.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17%
FCFM N/A
ROA(3y)-38.16%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 4.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.54%
Cap/Sales 1.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.55
Altman-Z -2.5
F-Score3
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)540.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-259.82%
OCF growth 3YN/A
OCF growth 5YN/A